DK1708711T3 - Sammensætninger, der især er anvendelige til behandling eller forebyggelse af metabolisk syndrom - Google Patents

Sammensætninger, der især er anvendelige til behandling eller forebyggelse af metabolisk syndrom

Info

Publication number
DK1708711T3
DK1708711T3 DK05708123.4T DK05708123T DK1708711T3 DK 1708711 T3 DK1708711 T3 DK 1708711T3 DK 05708123 T DK05708123 T DK 05708123T DK 1708711 T3 DK1708711 T3 DK 1708711T3
Authority
DK
Denmark
Prior art keywords
prevention
treatment
metabolic syndrome
enzyme inhibitor
oxidase enzyme
Prior art date
Application number
DK05708123.4T
Other languages
English (en)
Inventor
Sirpa Jalkanen
Marko Salmi
Markku Jalkanen
Original Assignee
Biotie Therapies Oyj
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34828616&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1708711(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from FI20040136A external-priority patent/FI20040136A0/fi
Application filed by Biotie Therapies Oyj filed Critical Biotie Therapies Oyj
Application granted granted Critical
Publication of DK1708711T3 publication Critical patent/DK1708711T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A61K31/51—Thiamines, e.g. vitamin B1
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Nutrition Science (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Endocrinology (AREA)
  • Immunology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Ophthalmology & Optometry (AREA)
  • Reproductive Health (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Emergency Medicine (AREA)
  • Dermatology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Vascular Medicine (AREA)
DK05708123.4T 2004-01-30 2005-01-19 Sammensætninger, der især er anvendelige til behandling eller forebyggelse af metabolisk syndrom DK1708711T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FI20040136A FI20040136A0 (fi) 2004-01-30 2004-01-30 Erityisesti diabeetikoille soveltuvia koostumuksia
US57889604P 2004-06-14 2004-06-14
PCT/FI2005/000035 WO2005072738A1 (en) 2004-01-30 2005-01-19 Compositions useful especially for treatment or prevention of metabolic syndrome

Publications (1)

Publication Number Publication Date
DK1708711T3 true DK1708711T3 (da) 2010-06-14

Family

ID=34828616

Family Applications (1)

Application Number Title Priority Date Filing Date
DK05708123.4T DK1708711T3 (da) 2004-01-30 2005-01-19 Sammensætninger, der især er anvendelige til behandling eller forebyggelse af metabolisk syndrom

Country Status (12)

Country Link
EP (1) EP1708711B1 (da)
JP (1) JP2007519688A (da)
AT (1) ATE460935T1 (da)
CA (1) CA2549029A1 (da)
CY (1) CY1110194T1 (da)
DE (1) DE602005019974D1 (da)
DK (1) DK1708711T3 (da)
ES (1) ES2342409T3 (da)
PL (1) PL1708711T3 (da)
PT (1) PT1708711E (da)
SI (1) SI1708711T1 (da)
WO (1) WO2005072738A1 (da)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI20060768A0 (fi) * 2006-08-28 2006-08-28 Faron Pharmaceuticals Oy Erityisesti metabolia-oireyhtymän hoitoon tai ehkäisyyn soveltuvia koostumuksia
US8119651B2 (en) 2004-01-30 2012-02-21 Biotie Therapies Corp. Compositions useful especially for treatment or prevention of metabolic syndrome
ITMI20050891A1 (it) * 2005-05-17 2006-11-18 Greenleaf S R L Formulazioni per il trattamento di psoriasi
TW200927100A (en) * 2007-10-19 2009-07-01 R Tech Ueno Ltd Pharmaceutical composition for treating cataract
UA112154C2 (uk) 2009-09-08 2016-08-10 Біоті Терапіс Корп. Застосування повністю людського анти-vap-1-антитіла для лікування фіброзних станів
US8802679B2 (en) 2009-09-16 2014-08-12 Astellas Pharma Inc. Glycine compound
JP6637500B2 (ja) * 2014-08-04 2020-01-29 コモンウェルス サイエンティフィック アンド インダストリアル リサーチ オーガナイゼーション ダイエット用食材を配合するための方法
CN108299485B (zh) * 2018-02-09 2020-05-12 湖北大学 一种用于检测活细胞内过氧化氢的荧光探针及其制备方法和应用
WO2021059275A1 (en) * 2019-09-26 2021-04-01 The State Of Israel, Ministry Of Agriculture & Rural Development, Agricultural Research Organization (Aro) (Volcani Center) Thiamine therapy for fatty liver associated diseases
CN110713986B (zh) * 2019-11-12 2023-05-12 江南大学 一株维生素b1单克隆抗体杂交瘤细胞株cbdd及其应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5441883A (en) * 1977-09-05 1979-04-03 Takeda Chem Ind Ltd Thiamine derivative and its preparation
US4558050A (en) * 1984-03-01 1985-12-10 University Of Florida Treatment of metabolic disorders with dichloroacetate-thiamine preparations
JPH01104142A (ja) * 1987-10-19 1989-04-21 Seibutsu Shigen Kenkyusho:Kk 消臭機能性食品及びその製造法
JP3942257B2 (ja) * 1998-01-06 2007-07-11 希能 澤口 機能性食品
PL360374A1 (en) † 2000-07-05 2004-09-06 Biotie Therapies Corporation Inhibitors of copper-containing amine oxidases
DE10043802A1 (de) 2000-09-06 2002-03-14 Daimler Chrysler Ag Achse für Fahrzeuge, insbesondere Nutzfahrzeuge
WO2002038153A1 (en) * 2000-11-09 2002-05-16 Biovitrum Ab New use of 4, 5, 6, 7-tetrahydroimidazo-[4,5-c]pyridine derivatives
JP2002193826A (ja) * 2000-12-26 2002-07-10 Fancl Corp 強壮・強精組成物
US6982286B2 (en) 2001-07-12 2006-01-03 Biotie Therapies Corp. Carbocyclic hydrazino inhibitors of copper-containing amine oxidases
KR101154163B1 (ko) † 2003-01-27 2012-06-14 아스텔라스세이야쿠 가부시키가이샤 티아졸 유도체 및 ｖａｐ-1 저해제로서의 용도

Also Published As

Publication number Publication date
JP2007519688A (ja) 2007-07-19
DE602005019974D1 (de) 2010-04-29
EP1708711B1 (en) 2010-03-17
EP1708711A1 (en) 2006-10-11
ATE460935T1 (de) 2010-04-15
CY1110194T1 (el) 2015-01-14
SI1708711T1 (sl) 2010-07-30
CA2549029A1 (en) 2005-08-11
WO2005072738A1 (en) 2005-08-11
ES2342409T3 (es) 2010-07-06
PL1708711T3 (pl) 2010-10-29
PT1708711E (pt) 2010-06-01

Similar Documents

Publication Publication Date Title
DK1708711T3 (da) Sammensætninger, der især er anvendelige til behandling eller forebyggelse af metabolisk syndrom
GEP20104974B (en) Carbonylamino pyrrolopyrazoles, protent kinase inhibitors
ATE511764T1 (de) Silizium enthaltende lebensmittel
WO2008021531A3 (en) Stabilized emulsions, methods of preparation, and related reduced fat foods
NO20081543L (no) Preparater omfattende darlig vannloselige farmasoytiske midler og antimikroielle midler
CL2009000316A1 (es) Compuestos derivados de urea de benzomorfanos y sus sales, inhibidores de la enzima 11-beta-hidroxiesteroide deshidrogenasa; procedimiento de preparacion; composicion farmaceutica; y uso para el tratamiento o prevencion de trastornos metabolicos.
EA200702340A1 (ru) Противообледенительная и/или антиобледенительная композиция, способ ее получения, жидкое средство для понижения температуры замерзания на ее основе и способ удаления и/или предотвращения образования льда
WO2008151807A3 (de) Hitzestabile asparaginase zur reduktion von acrylamid in nahrungs- oder genussmitteln
NO20075009L (no) Ernaeringstilsetning for HIV-pasienter
WO2008079610A3 (en) Novel acetyl-coa carboxylase (acc) inhibitors and their use in diabetes, obesity and metabolic syndrome
TW200734306A (en) Novel compounds, their preparation and use
CL2007001945A1 (es) Compuestos derivados de alquilpiridazina, inhibidores de 11 beta-hsd1; proceso de obtencion de los compuestos; composicion farmaceutica que los comprenden; y usos en el tratamiento de la diabetes, obesidad, trastorno de ingestion de comida, dislipide
SMT201300080B (it) Derivati di carbammati di alchiltiazoli, loro preparazione e loro utilizzo come inibitori dell'enzima faah
WO2008057300A3 (en) Trpvi antagonists and uses thereof
EA201070967A1 (ru) Улучшенные ароматизированные кондитерские продукты
WO2008123128A1 (ja) アディポネクチン産生促進剤
DK1827136T3 (da) Sammensætning til oral indgivelse med sundhedsfremmende virkning på hjerte-kredslöbs-systemet
WO2016085321A3 (en) Composition comprising a pentose and polyphenolic compound
WO2007070563A3 (en) Stable solid forms of enterostatin
EA200870187A1 (ru) Пищевой продукт с гасителем вкуса и способ его изготовления
BR112012015925A2 (pt) composição compreendendo uma combinação de pelo menos uma enzima proteolítica e pelo menos uma enzima lipolitica e produto"
WO2012081831A3 (en) Composition comprising the extract of loranthus yadoriki sieb having monoamine oxidase-inhibiting activity
WO2010077317A3 (en) Protease inhibitors
WO2010075086A3 (en) Pyrrolidinone inhibitors of pde-4
DE602007008943D1 (de) Kochvorrichtung